Stock listing
NASDAQ:LEXX Lexaria Bioscience Corp. Stock
Home listing (NASDAQ) of Lexaria Bioscience Corp.
Follow Lexaria Bioscience Corp. into a list and get an email when it puts out news.
Share price · NASDAQ:LEXX
$3.49 USD -0.28 (-7.4%)
Close on Oct 30, 2026
- Day range
- $3.21 – $3.63 USDOct 30, 2026
- Volume
- 37,694 sharesOct 30, 2026
- Market cap
- $7.35M USDAt the close on Oct 30, 2026 · price × 2.11M shares outstanding
- 52-week range
- $2.43 – $21.60 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $452,682 USDMedian day 43,250 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:LEXX · Home | $3.49 USD | -0.28 (-7.4%) | 37,694 | $3.63 | $3.63 | $3.21 | $3.77 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:LEXX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.49 | -0.28 | -7.4% | $3.63 | $3.63 | $3.21 | 37,694 | |
| $3.77 | +0.47 | +14.2% | $3.38 | $3.87 | $3.30 | 38,984 | |
| $3.30 | +0.08 | +2.5% | $3.18 | $3.55 | $3.065 | 38,919 | |
| $3.22 | +0.30 | +10.3% | $3.10 | $3.31 | $2.96 | 41,763 | |
| $2.92 | -0.16 | -5.2% | $3.08 | $3.08 | $2.83 | 13,831 | |
| $3.08 | +0.09 | +3.0% | $2.98 | $3.199 | $2.84 | 23,200 | |
| $2.99 | +0.17 | +6.0% | $2.74 | $3.00 | $2.51 | 16,500 | |
| $2.82 | +0.17 | +6.4% | $2.68 | $2.89 | $2.516 | 28,700 | |
| $2.65 | +0.05 | +1.9% | $2.60 | $2.68 | $2.46 | 41,900 | |
| $2.60 | -0.26 | -9.1% | $2.79 | $2.85 | $2.43 | 44,600 | |
| $2.86 | -0.13 | -4.3% | $3.19 | $3.24 | $2.81 | 123,900 | |
| $2.99 | +0.17 | +6.0% | $2.74 | $3.11 | $2.74 | 37,200 | |
| $2.82 | +0.02 | +0.7% | $2.81 | $2.92 | $2.43 | 103,900 | |
| $2.80 | -0.47 | -14.4% | $3.29 | $3.29 | $2.69 | 117,900 | |
| $3.27 | -0.05 | -1.5% | $3.18 | $3.624 | $3.18 | 66,100 | |
| $3.32 | +0.12 | +3.7% | $3.31 | $3.90 | $3.12 | 198,400 | |
| $3.20 | -0.26 | -7.5% | $3.50 | $3.669 | $3.19 | 26,500 | |
| $3.46 | +0.22 | +6.8% | $3.14 | $3.59 | $3.10 | 76,900 | |
| $3.24 | +0.47 | +17.0% | $2.925 | $3.24 | $2.86 | 66,100 | |
| $2.77 | -0.11 | -3.8% | $2.90 | $3.125 | $2.77 | 38,700 | |
| $2.88 | -0.21 | -6.8% | $3.18 | $3.24 | $2.80 | 80,100 | |
| $3.09 | -0.06 | -1.9% | $3.20 | $3.25 | $2.95 | 48,700 | |
| $3.15 | +0.02 | +0.6% | $3.21 | $3.29 | $3.06 | 23,100 | |
| $3.13 | -0.095 | -2.9% | $3.28 | $3.34 | $2.98 | 77,500 | |
| $3.225 | -0.055 | -1.7% | $3.25 | $3.46 | $3.15 | 41,900 | |
| $3.28 | -0.09 | -2.7% | $3.455 | $3.455 | $3.15 | 34,200 | |
| $3.37 | +0.135 | +4.2% | $3.29 | $3.595 | $3.142 | 51,800 | |
| $3.235 | +0.015 | +0.5% | $3.31 | $3.34 | $3.10 | 14,400 | |
| $3.22 | -0.205 | -6.0% | $3.54 | $3.84 | $3.08 | 107,300 | |
| $3.425 | +0.185 | +5.7% | $3.29 | $3.48 | $3.15 | 26,000 | |
| $3.24 | -0.05 | -1.5% | $3.25 | $3.52 | $3.15 | 76,300 | |
| $3.29 | +0.195 | +6.3% | $3.07 | $4.00 | $2.91 | 161,400 | |
| $3.095 | -0.115 | -3.6% | $3.28 | $3.47 | $2.80 | 150,400 | |
| $3.21 | -0.34 | -9.6% | $3.54 | $3.932 | $2.98 | 123,700 | |
| $3.55 | -0.42 | -10.6% | $3.98 | $4.15 | $3.14 | 178,900 | |
| $3.97 | -0.08 | -2.0% | $4.15 | $4.72 | $3.645 | 195,900 | |
| $4.05 | -2.55 | -38.6% | $7.00 | $7.50 | $4.04 | 223,500 | |
| $6.60 | -2.77 | -29.6% | $9.44 | $9.52 | $6.405 | 74,300 | |
| $9.37 | -4.78 | -33.8% | $11.09 | $11.09 | $8.81 | 121,200 | |
| $14.15 | +1.83 | +14.9% | $12.26 | $14.37 | $12.26 | 22,400 | |
| $12.32 | -0.885 | -6.7% | $13.33 | $13.93 | $12.25 | 74,700 | |
| $13.21 | +0.73 | +5.9% | $12.63 | $13.61 | $12.40 | 40,900 | |
| $12.48 | +1.195 | +10.6% | $11.13 | $12.89 | $11.13 | 65,400 | |
| $11.28 | +0.93 | +9.0% | $10.30 | $12.20 | $10.30 | 359,500 | |
| $10.35 | -1.33 | -11.4% | $11.42 | $12.48 | $10.35 | 61,900 | |
| $11.68 | +0.64 | +5.8% | $10.97 | $11.78 | $10.24 | 505,600 | |
| $11.04 | -0.56 | -4.8% | $11.70 | $11.90 | $11.00 | 5,200 | |
| $11.60 | +1.06 | +10.1% | $10.75 | $11.60 | $10.60 | 12,300 | |
| $10.54 | -0.375 | -3.4% | $10.96 | $11.10 | $10.41 | 14,900 | |
| $10.92 | -0.355 | -3.1% | $11.38 | $11.53 | $10.80 | 8,900 | |
| $11.27 | -0.24 | -2.1% | $11.96 | $12.89 | $11.24 | 67,100 | |
| $11.51 | -0.01 | -0.1% | $11.93 | $11.98 | $11.06 | 130,100 | |
| $11.52 | +1.20 | +11.6% | $10.18 | $12.12 | $10.18 | 32,300 | |
| $10.32 | +1.28 | +14.2% | $9.31 | $10.46 | $8.74 | 35,100 | |
| $9.04 | +0.94 | +11.6% | $7.99 | $9.18 | $7.975 | 15,400 | |
| $8.10 | +1.98 | +32.4% | $6.08 | $8.26 | $5.95 | 94,100 | |
| $6.12 | +0.33 | +5.7% | $5.75 | $6.15 | $5.60 | 15,000 | |
| $5.79 | +0.30 | +5.5% | $5.50 | $5.99 | $5.50 | 8,800 | |
| $5.49 | +0.22 | +4.2% | $5.27 | $5.49 | $5.27 | 9,600 | |
| $5.27 | -0.07 | -1.3% | $5.34 | $5.73 | $5.27 | 20,800 | |
| $5.34 | -0.33 | -5.8% | $5.60 | $5.735 | $5.325 | 16,100 | |
| $5.67 | +0.05 | +0.9% | $5.68 | $6.09 | $5.23 | 72,200 | |
| $5.62 | +0.87 | +18.3% | $4.64 | $5.69 | $4.615 | 68,600 | |
| $4.75 | -1.115 | -19.0% | $5.90 | $5.90 | $4.21 | 61,100 | |
| $5.865 | -0.075 | -1.3% | $5.67 | $6.39 | $5.25 | 2,171 | |
| $5.94 | -2.01 | -25.3% | $7.80 | $8.25 | $5.595 | 3,255 |
- Ticker
- NASDAQ:LEXX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 28, 2026
Lexaria Celebrates its 70th Patent Award
Latest news
Lexaria Celebrates its 70th Patent Award
Oct 28, 2026
Closed $3.30 (+2.5%) on Oct 28, 2026
Lexaria's Human Study GLP-1-H26-7 Reaches Full Enrollment and Continues Dosing on Schedule
Oct 21, 2026
Closed $2.82 (+6.4%) on Oct 21, 2026
Lexaria Announces Results From Animal Study GLP-1-A26-1
Oct 15, 2026
Closed $2.99 (+6.0%) on Oct 15, 2026
Lexaria Updates Financial Position
Sep 17, 2026
Closed $3.29 (+6.3%) on Sep 17, 2026
Lexaria Bioscience Announces Closing of Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
Sep 9, 2026
Closed $4.05 (-38.6%) on Sep 10, 2026
Lexaria Announces Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
Sep 8, 2026
Closed $9.37 (-33.8%) on Sep 8, 2026
Lexaria to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 4, 2026
Closed $14.15 (+14.9%) on Sep 4, 2026
Lexaria Receives USD$2.6 Million Tax Rebate Payment
Sep 1, 2026
Closed $12.48 (+10.6%) on Sep 1, 2026
Lexaria Enters a Material Transfer Agreement With PegBio
Aug 13, 2026
Closed $8.10 (+32.4%) on Aug 13, 2026
Lexaria Announces Effective Date for Reverse Stock Split
Jul 30, 2026
Closed $5.94 (-25.3%) on Jul 30, 2026
Financings
Common stock on exercise of existing warrants at a reduced price, with new unregistered Series A and Series B warrants
Sep 9, 2026
Closed: US$5.9M raised · US$12.92 a share · Warrants at US$12.67 · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Working capital and general corporate purposes
Decks
Investor Presentation (December 2020)
Investor deck · 30 slides · Dec 31, 2020
Investor Presentation (July 2019)
Investor deck · 27 slides · July 2019
Investor Presentation (November 2017)
Investor deck · 16 slides · Nov 2, 2017
Lexaria Bioscience Corp. on 6ix
- News releases
- 33 in the last 12 months · 185 in all · newest Oct 28, 2026 · oldest 2021
- Decks
- 3 decks · latest Dec 31, 2020
Where Lexaria Bioscience Corp. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:LEXX · Home listing · This page | NASDAQ | United States | USD |
| BOATS:LEXX | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Lexaria Bioscience Corp.